Kanichi Research Services

Healthcare
Seed Investment
2016

Kanichi Research Services are developing novel non-invasive diagnostic systems that measure analytes in exhaled breath for the rapid detection and diagnosis of a range of diseases. The lead product is a low-cost, disposable, point of care test for the detection and diagnosis of Helicobacter Pylori (H. pylori), a bacterial infection in the gut which can lead to stomach ulcers and stomach cancer.

Kanichi's breath sensor technology has huge market potential with numerous advantages over current diagnostic tests.

Our Approach

What do we look for?

Our business is about forming long term relationships with exceptional entrepreneurs and becoming a trusted partner and supportive investor.

We look for companies with both the vision and potential to become ‘game changers’ and market leaders across a range of sectors.

learn more

Our Team

Hamish Graham

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
Enderby
Leicester
LE19 4XT

Tel: 0116 238 8200

email